Tuesday
June 24, 2025
8:05 AM ET
Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
Monday
May 12, 2025
6:26 PM ET
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
Monday
May 12, 2025
4:00 PM ET
Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day
Tuesday
May 6, 2025
4:35 PM ET
Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
Monday
March 17, 2025
4:01 PM ET
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Thursday
March 6, 2025
4:05 PM ET
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference